Left ventricular assist device as a bridge to recovery: Present status

Journal of Cardiac Surgery

Volumn 16, Issue 4, 2001, Pages 294-301

  Kumpati, Ganesh S ^a   McCarthy, Patrick M ^a   Hoercher, Katherine J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CONFERENCE PAPER; EXPLANT; HEART ASSIST DEVICE; HEART DILATATION; HEART LEFT VENTRICLE; HEMODYNAMIC MONITORING; HORMONE DETERMINATION; HUMAN; IMPLANT; MALE; MOLECULAR DYNAMICS; MYOCARDITIS; TECHNOLOGY; WEANING;

ADULT; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RECOVERY OF FUNCTION;

EID: 0035701476     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb00524.x     Document Type: Article

References (57)

1. Left ventricular bypass pump for cardiac assistance
2. Orthotopic cardiac prosthesis for two-staged cardiac replacement
3. Long-term follow-up of postcardiotomy patients with profound cardiogenic shock treated with ventricular assist device
4. Ventricular assist devices for postcardiotomy cardiogenic shock
5. Clinical experience with the Novacor ventricular assist system
6. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology
7. One hundred long-term implantable left ventricular assist devices: The Columbia-Presbyterian interim experience
8. Left ventricular assist devices: Current status and future applications
9. Mechanisms and models in heart failure: A combinatorial approach
10. Cardiac remodeling as a consequence and cause of progressive heart failure
11. Ventricular remodeling-mechanisms and prevention
12. The role of cytokines in the failing human heart
13. Beta-1 and Beta-2 adrenergic receptor subpopulations in nonfailing and failing human myocardium: Coupling of both receptor subtypes and selective Beta-1 receptor down-regulation in heart failure
14. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure
15. Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium
16. Improved ventricular function after chronic left ventricular unloading
17. Left ventricular assist device-induced reverse ventricular remodeling
18. Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device
19. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading
20. Exercise capacity recovers slowly but fully in patients with a left ventricular assist device
21. Exercise hemodynamics during long-term implantation of a left ventricular assist device in patients awaiting heart transplantation
22. Effects of exercise during long-term support with a left ventricular assist device
23. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: Results of the experience with left ventricular assist device with exercise trial
24. Myocardial recovery after mechanical support for acute myocarditis: Is sustained recovery predictable?
25. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
26. The effect of prolonged left ventricular support on myocardial histopathology in patients with end-stage cardiomyopathy
27. Regression of cellular hypertrophy after left ventricular assist device support
28. Structural and left ventricular histologic changes after implantable LVAD insertion
29. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy
30. Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure
31. Alterations in calcium cycling proteins and Gαq signaling after left ventricular assist device support in failing human hearts
32. Decreased expression of tumor necrosis factor-α in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery
33. Reduced myocardial matrix metalloproteinase expression as a result of sustained mechanical support with left ventricular assist devices in patients with severe dilated cardiomyopathy
34. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy: First results of the Halle assist induced recovery study (HAIR)
35. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure
36. The effect of sustained mechanical support with left ventricular assist devices on myocardial apoptosis in patients with severe dilated cardiomyopathy
37. Anti-β1-adrenoreceptor autoantibodies: A marker of ventricular recovery in patients with left ventricular assist devices
38. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels
39. Neurohormonal changes after implantation of a left ventricular assist system
40. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure
41. The effect of chronic mechanical circulatory support on neuroendocrine activation in patients with end-stage heart failure
42. Case report: Circulatory support for seventy days with resolution of acute heart failure
43. Acute fulminant myocarditis: Long-term follow-up after circulatory support with left ventricular device
44. Temporary left-sided mechanical cardiac support during acute myocarditis
45. Management of acute fulminant myocarditis using circulatory support systems
46. Bridge to recovery with a left ventricular assist device for fulminant acute myocarditis
47. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis
48. Temporary mechanical support with BVS 5000 assist device during treatment of acute myocarditis
49. Mechanical bridge to recovery in fulminant myocarditis
50. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy
51. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure
52. Left ventricular assist system as a bridge to myocardial recovery
53. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device
54. Mechanical support in dilated cardiomyopathy: Signs of early cardiac recovery
55. Successful mechanical circulatory support for more than two years with a ventricular assist device in a patient with dilated cardiomyopathy
56. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy
57. Weaning from mechanical cardiac support in patients with dilated cardiomyopathy